India – Delhi High Court Refuses To Vacate Interim Injunction Granted In Favour Of Novartis For Compound Ceritinib.

- Manisha Singh - Lex Orbis,

Patentable Category Of Claims In India- Method Of Treatment Or Method Of Producing A Novel Substance For Medical Application?

- Manisha Singh - Lex Orbis,

India – Method of Agriculture Under Section 3(h): Limits And Reach.

- DPS Parmar - Lex Orbis,

India – Cyril Amarchand Mangaldas Advised BRLMs In Relation To Initial Public Offering Of Awfis Space Solutions Limited.

GCC Series: Setting-Up Global In-house Centres (GICs) In India: Key Regulatory Considerations.

India – Summoning Additional Accused In Criminal Trial: When, Why And How.

India – Ultimate Parent’s Professional CEO A Significant Beneficial Owner: Do Companies Have To Re-Evaluate Their Corporate Approval Process And Reporting Line Structures?

- Bharat Vasani - Cyril Amarchand Mangaldas,

India – Impact Of The Jan Vishwas Act, 2023 On The Pharmaceuticals Industry – Decriminalizing Minor Offences One Step At A Time.

A Review Of The Performance Of Surety Insurance Contracts In India.

- Indranath Bishnu - Partner, Cyril Amamrchand Mangaldas

India – Analysis Of SEBI’s Consultation Paper On Valuation Framework For AIFs.

- Vivaik Sharma - Cyril Amarchand Mangaldas, Cyril Amarchand Mangaldas

India – SEBI Recognises Stock Exchanges As Supervisory And Administrative Body For Investment Advisers And Research Analysts.

- Vivaik Sharma - Cyril Amarchand Mangaldas, Cyril Amarchand Mangaldas

India – Cyril Amarchand Mangaldas Advised TBO Tek Limited On Its Initial Public Offering Of Equity Shares Aggregating To INR 15508 Million.